Astal Laboratories share news and announcements
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Last close ₹63.81down ₹4.04 (5.95%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.85.
52-week range of traded prices to 23 Oct 2026
₹60.45Low, 27 Apr 2026₹102.00High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹279 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 28.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 13,208
Astal Laboratories board meetings
135 filed, newest first. Page 1 of 3.
Sep 2026
4 Sep · Board meeting
Aug 2026
31 Aug · Board meeting
Meeting on 4 Sep 2026: annual general meeting10 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
Jun 2026
29 Jun · Board meeting
May 2026
25 May · Board meeting
Meeting on 30 May 2026: quarterly results and audited results25 May · Board meeting
12 May · Board meeting
Feb 2026
10 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
14 Jan · Board meeting
Nov 2025
10 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Oct 2025
9 Oct · Board meeting
3 Oct · Board meeting
Meeting on 9 Oct 2025: increase in authorised capital and preferential issue of shares
Aug 2025
6 Aug · Board meeting
Meeting on 12 Aug 2025: annual general meeting and quarterly results
May 2025
13 May · Board meeting
Meeting on 19 May 2025: audited results
Jan 2025
21 Jan · Board meeting
Meeting on 27 Jan 2025: quarterly results
Nov 2024
22 Nov · Board meeting
Meeting on 27 Nov 20246 Nov · Board meeting
Meeting on 12 Nov 2024: quarterly results
Jul 2024
22 Jul · Board meeting
Meeting on 27 Jul 2024: quarterly results
Jun 2024
28 Jun · Board meeting
Meeting on 6 Jul 2024: annual general meeting and issue of warrants
May 2024
18 May · Board meeting
Meeting on 24 May 2024: audited results and quarterly results
Feb 2024
2 Feb · Board meeting
Meeting on 9 Feb 2024: quarterly results
Dec 2023
15 Dec · Board meeting
Meeting on 20 Dec 2023: increase in authorised capital and preferential issue of shares8 Dec · Board meeting
Meeting on 8 Dec 2023
Nov 2023
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results